Comparing the simplified and international autoimmune hepatitis group criteria in primary sclerosing cholangitis

Gastroenterology and Hepatology

Volumn 6, Issue 2, 2010, Pages 108-112

  Chandok, Natasha ^a   Silveira, Marina G ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmune hepatitis scoring system; Overlap syndrome; Primary biliary cirrhosis

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CHOLANGIOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGY;

EID: 77950523029     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Montano-Loza AJ, Carpenter HA, Czaja AJ. Consequences of treatment withdrawal in type 1 autoimmune hepatitis. Liver Int. 2007;27:507-515.
2. Krawitt EL. Clinical features and management of autoimmune hepatitis. World J Gastroenterol. 2008;14:3301-3305.
3. Czaja AJ. Autoimmune liver disease. Curr Opin Gastroenterol. 2008;24:298-305.
4. Czaja AJ. Diverse manifestations and evolving treatments of autoimmune hepatitis. Minerva Gastroenterol Dietol. 2005;51:313-333.
5. Woodward J, Neuberger J. Autoimmune overlap syndromes. Hepatology. 2001;33:994-1002.
6. Ben-Ari Z, Czaja AJ. Autoimmune hepatitis and its variant syndromes. Gut. 2001;49:589-594.
7. Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol. 2008;14:3368-3373.
8. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology. 1998;28:360-365.
9. Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system. J Hepatol. 2000;33:537-542.
10. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125:588-598.
11. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929-938.
12. Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology. 2008;48:1540-1548.
13. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169-176.
14. Lindor KD. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med. 1997;336:691-695.
15. Lindor KD, Kowdley KV, Luketic VAC, Harrison ME, McCashland T, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology. In press.
16. Czaja AJ. Autoimmune hepatitis. Part B: diagnosis. Expert Rev Gastroenterol Hepatol. 2007;1:129-143.
17. Perdigoto R, Carpenter HA, Czaja AJ. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol. 1992;14:325-331.
18. Silveira MG, Lindor KD. Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases. Expert Rev Gastroenterol Hepatol. 2007;1:329-340.